Global Review 2021 – The Intersection of PGx and Prescribing

15 Mar Global Review 2021 – The Intersection of PGx and Prescribing

Posted at 09:46h in Uncategorized by
0 Likes

References

1 – https://www.futuremedicine.com/doi/10.2217/pgs-2019-0134

2 – https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html

3 – https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-73

4 – https://pubmed.ncbi.nlm.nih.gov/24798722/

5 – https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling

6 – https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642

7 – https://www.reuters.com/article/us-bristol-myers-sanofi-plavix-idUSKBN2AF1YI

8 – https://www.einnews.com/pr_news/560810526/pharmacogenomics-market-is-estimated-to-reach-usd-11-97-billion-by-2028-emergen-research#:~:text=RESEARCH%20%2D%20EIN%20Presswire-,Pharmacogenomics%20Market%20is%20estimated%20to%20reach,billion%20by%202028%3A%20EMERGEN%20RESEARCH&text=Pharmacogenomics%20Market%20trends%20%E2%80%93%20Growing%20demand%20for%20personalized%20therapy

No Comments

Sorry, the comment form is closed at this time.